» Articles » PMID: 22006653

The Influence of Schizophyllum Commune on Asthma Severity

Overview
Journal Lung
Specialty Pulmonary Medicine
Date 2011 Oct 19
PMID 22006653
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The sensitization and exposure to fungal allergens have been reported to be associated with asthma. The aim of this study was to clarify the impact of sensitization to Schizophyllum commune (S. commune) on the severity and exacerbations of asthma.

Methods: Ninety-two patients with asthma of various levels of severity [mild (n = 18), moderate (28), and severe (46)] and exacerbation severity [moderate (n = 43) and severe (6)] were retrospectively examined with regard to fungal sensitization such as specific IgE or intradermal skin reactions against S. commune and other common allergens. We also classified the patients into three groups: (1) three or more asthma attacks during the past year (F-BA) (n = 29),(2) one or two asthma attacks (NF-BA) (n = 20), and (3) no asthma attack (C-BA) (n = 43).

Results: The positive rate of late cutaneous reactions to S. commune was higher in patients with severe asthma (41.2%) than with moderate (26.1%) or mild asthma (6.7%), and was significantly different among the three groups (P < 0.05). Although the ratio did not show a significant difference between the patients with severe (83.3%) or moderate (36.1%) exacerbation, it was higher in F-BA (60.9%) than in NF-BA (21.1%) and C-BA patients (10.0%), and it was significantly different among the three groups (P = 0.0002). Multivariate analysis identified positive results for late-phase skin reactions to S. commune and the age of the patients as an independent determinant of asthma severity, and the skin results and %FVC an independent determinant of exacerbation frequency.

Conclusion: This study demonstrated that S. commune is an environmental fungus that appears to enhance both the severity of asthma and the exacerbation frequency.

Citing Articles

The Interactions of Airway Bacterial and Fungal Communities in Clinically Stable Asthma.

Liu H, Li C, Liang Z, Zhang S, Yang W, Ye Y Front Microbiol. 2020; 11:1647.

PMID: 32849339 PMC: 7396634. DOI: 10.3389/fmicb.2020.01647.


Schizophyllum commune induces IL-17-mediated neutrophilic airway inflammation in OVA-induced asthma model mice.

Hanashiro J, Muraosa Y, Toyotome T, Hirose K, Watanabe A, Kamei K Sci Rep. 2019; 9(1):19321.

PMID: 31852931 PMC: 6920419. DOI: 10.1038/s41598-019-55836-x.


Schizophyllum commune-induced Pulmonary Mycosis.

Shen Q, Yao Y, Yang Q, Zhou J Chin Med J (Engl). 2016; 129(17):2141-2.

PMID: 27569249 PMC: 5009606. DOI: 10.4103/0366-6999.189062.


Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis?.

Chowdhary A, Agarwal K, Meis J PLoS Pathog. 2016; 12(4):e1005491.

PMID: 27124489 PMC: 4849718. DOI: 10.1371/journal.ppat.1005491.


Schizophyllum commune-induced allergic fungal rhinosinusitis and sinobronchial mycosis.

Tsukatani T, Ogawa H, Anzawa K, Kobayashi E, Hasegawa H, Makimura K Med Mycol Case Rep. 2015; 8:10-3.

PMID: 25756007 PMC: 4348453. DOI: 10.1016/j.mmcr.2015.02.004.


References
1.
Denning D, ODriscoll B, Powell G, Chew F, Atherton G, Vyas A . Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med. 2008; 179(1):11-8. DOI: 10.1164/rccm.200805-737OC. View

2.
Helbling A, Brander K, Horner W, Lehrer S . Allergy to basidiomycetes. Chem Immunol. 2002; 81:28-47. DOI: 10.1159/000058861. View

3.
Platts-Mills T, Woodfolk J . Trichophyton asthma. Chest. 2009; 135(4):887-888. DOI: 10.1378/chest.09-0114. View

4.
Jung J, Choi J, Shin J, Kim J, Park I, Choi B . Clinical characteristics according to sensitized allergens in adult korean patients with bronchial asthma. Allergy Asthma Immunol Res. 2010; 2(2):102-7. PMC: 2846732. DOI: 10.4168/aair.2010.2.2.102. View

5.
Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F . Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol. 1999; 103(4):709-11. DOI: 10.1016/s0091-6749(99)70247-2. View